Literature DB >> 17157801

The Amblyopia and Strabismus Questionnaire: English translation, validation, and subscales.

Joost Felius1, George R Beauchamp, David R Stager, Elizabeth S Van De Graaf, Huibert J Simonsz.   

Abstract

PURPOSE: To establish the English-language version of the Amblyopia and Strabismus Questionnaire (ASQE).
DESIGN: Prospective cohort study.
METHODS: A structured translation process was followed to generate the ASQE, a 26-item instrument (originally in Dutch) containing five subscales for fear of losing the better eye, distance estimation, visual disorientation, double vision, and social contact and appearance. The ASQE was administered to 150 adults in a private practice setting. All had strabismus with or without amblyopia and visual acuity of 20/50 or better in at least one eye. Subjects also completed a brief disability questionnaire, and they were further characterized by levels of unilateral vision loss, diplopia, and asthenopia.
RESULTS: ASQE scores were highly correlated with the disability questionnaire outcomes (r = -.76, P < .0001). Internal consistency reliability (Cronbach alpha) of the subscales ranged from 0.80 to 0.92. Strong correlations were found between clinical characteristics and the ASQE (total score and subscale scores).
CONCLUSIONS: The ASQE showed good psychometric properties that are in line with those of the original instrument. This, combined with strong correlations between ASQE scores and clinical characterization of the participants, establishes the ASQE as a useful tool for use in populations with strabismus and/or amblyopia.

Entities:  

Mesh:

Year:  2006        PMID: 17157801     DOI: 10.1016/j.ajo.2006.09.046

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  21 in total

1.  Quality of life and functional vision concerns of children with cataracts and their parents.

Authors:  Y S Castañeda; C S Cheng-Patel; D A Leske; S M Wernimont; S R Hatt; L Liebermann; E E Birch; J M Holmes
Journal:  Eye (Lond)       Date:  2016-07-08       Impact factor: 3.775

2.  Occlusion therapy for amblyopia.

Authors:  Sjoukje E Loudon; Huibert J Simonsz
Journal:  BMJ       Date:  2007-10-06

3.  Binocular inhibition in strabismic patients is associated with diminished quality of life.

Authors:  Anika K Tandon; Federico G Velez; Sherwin J Isenberg; Joseph L Demer; Stacy L Pineles
Journal:  J AAPOS       Date:  2014-09-27       Impact factor: 1.220

Review 4.  Health-related quality of life measures (HRQoL) in patients with amblyopia and strabismus: a systematic review.

Authors:  Jill Carlton; Eva Kaltenthaler
Journal:  Br J Ophthalmol       Date:  2010-08-07       Impact factor: 4.638

5.  A dichoptic custom-made action video game as a treatment for adult amblyopia.

Authors:  Indu Vedamurthy; Mor Nahum; Samuel J Huang; Frank Zheng; Jessica Bayliss; Daphne Bavelier; Dennis M Levi
Journal:  Vision Res       Date:  2015-04-24       Impact factor: 1.886

6.  [Quality of life - methodology and clinical practice aspects with a focus on ocular medicine].

Authors:  G H Franke; C Gall
Journal:  Ophthalmologe       Date:  2008-08       Impact factor: 1.059

7.  Comparison of quality-of-life instruments in adults with strabismus.

Authors:  Sarah R Hatt; David A Leske; Elizabeth A Bradley; Stephen R Cole; Jonathan M Holmes
Journal:  Am J Ophthalmol       Date:  2009-07-01       Impact factor: 5.258

8.  The effects of strabismus on quality of life in adults.

Authors:  Sarah R Hatt; David A Leske; Penny A Kirgis; Elizabeth A Bradley; Jonathan M Holmes
Journal:  Am J Ophthalmol       Date:  2007-08-20       Impact factor: 5.258

9.  Development of a quality-of-life questionnaire for adults with strabismus.

Authors:  Sarah R Hatt; David A Leske; Elizabeth A Bradley; Stephen R Cole; Jonathan M Holmes
Journal:  Ophthalmology       Date:  2008-11-18       Impact factor: 12.079

10.  Construct validation of the Amblyopia and Strabismus Questionnaire (A&SQ) by factor analysis.

Authors:  Elizabeth S van de Graaf; Joost Felius; Hanneke van Kempen-du Saar; Casper W N Looman; Jan Passchier; Henk Kelderman; Huibert J Simonsz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-06-03       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.